Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Basic Chondroitin Sulfate Sodium

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Chondroitin Sulfate Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 61Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Release Group Standard Sodium Chondroitin Sulfate For Medical Devices
    Release Group Standard Sodium Chondroitin Sulfate For Medical Devices

    28 Nov 2024

    // PRESS RELEASE

    https://www.topscience.cn/en/newsInfo1259.html

    PRESS RELEASE
    28 Nov 2024
    Share Share
    Bioiberica expands its chondroprotection line and launches Condrovet® Force HA for Large Breeds for dogs over 25 kilos
    Bioiberica expands its chondroprotection line and launches Condrovet® Force HA for Large Breeds for dogs over 25 kilos

    30 Nov 2020

    // PRESS RELEASE

    https://www.bioiberica.com/en/media/news/companion-animal-health/bioiberica-expands-its-chondroprotection-line-and-launches-condrovet-force-ha-large-breeds-dogs-over-25-kilos

    PRESS RELEASE
    30 Nov 2020
    Share Share
    Reig Jofre acquires Bioiberica’s portfolio of finished pharmaceutical and nutraceutical products, and establishes a strategic agreement to develop the joint health market
    Reig Jofre acquires Bioiberica’s portfolio of finished pharmaceutical and nutraceutical products, and establishes a strategic agreement to develop the joint health market

    01 Jul 2019

    // PRESS RELEASE

    https://www.bioiberica.com/en/media/news/bioiberica/reig-jofre-acquires-bioibericas-portfolio-finished-pharmaceutical-and-nutraceutical-products-and-establishes-strategic

    PRESS RELEASE
    01 Jul 2019
    Share Share
    Chinese heparin maker banned by EMA over contamination risks
    Chinese heparin maker banned by EMA over contamination risks

    28 Nov 2018

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/chinese-heparin-maker-banned-by-ema-over-contamination-risks

    Eric Palmer FIERCE PHARMA
    28 Nov 2018
    Share Share
    CDRH Finalizes Guidance to Reduce Heparin Product Overdose Errors
    CDRH Finalizes Guidance to Reduce Heparin Product Overdose Errors

    19 Sep 2018

    // Ana Mulero RAPS

    https://www.raps.org/news-and-articles/news-articles/2018/9/cdrh-finalizes-guidance-to-reduce-heparin-product?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2019%20September

    Ana Mulero RAPS
    19 Sep 2018
    Share Share
    EU OKs first treatment for ultra rare lysosomal storage disorder
    EU OKs first treatment for ultra rare lysosomal storage disorder

    29 Aug 2018

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/eu_oks_first_treatment_for_ultra_rare_lysosomal_storage_disorder_1250598

    Selina McKee PHARMA TIMES
    29 Aug 2018
    Share Share